Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
147
Frequently Asked Questions
What is Market Cap of Codex DNA Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Codex DNA Inc market cap is $9.58M.
What is the 52-week high for Codex DNA Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Codex DNA Inc 52 week high is $3.01 as of September 22, 2025.
What is the 52-week low for Codex DNA Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Codex DNA Inc 52 week low is $0.2997 as of September 22, 2025.
What is Codex DNA Inc stock price today?
Codex DNA Inc stock price today is $0.316.
What was Codex DNA Inc stock price yesterday?
Codex DNA Inc stock price yesterday was $0.3213.
What is the PE ratio of Codex DNA Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Codex DNA Inc’s P/E ratio is -0.19.
What is the Price-to-Book ratio of Codex DNA Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Codex DNA Inc P/B ratio is 40.2020.
What is Codex DNA Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Codex DNA Inc's EBITDA is -1.81.
What is the 50-day moving average of Codex DNA Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Codex DNA Inc 50-day moving average is $0.4518.